ArticleMicrobiology (Reading, England)2018
Efficient bio-production of citramalate using an engineered Escherichia coli strain.
Article in Microbiology (Reading, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 41 citations in OpenAlex.
- Development of a chemometric platform for mid-infrared fermentation monitoring.Scientific reports · 2026Article
- Regulation of Escherichia coli fermentation processes: from molecular mechanisms to smart industrial practice.Archives of microbiology · 2026Review
- An Unorthodox Enolate-Triggered Radical Relay Directs the Chemo Upgrading of Levulinic Acid Into Citramalic Acid.ChemSusChem · 2026Article
- The generation game: Toward the generational genetic stability of continuous culture.iScience · 2025Article
- Enhancing the stability of continuous fermentations for platform chemical production.iScience · 2025Article
- Enhancing genome-scale metabolic models with kinetic data: resolving growth and citramalate production trade-offs inBioinformatics advances · 2025Article
- Improving productivity of citramalate from COBiotechnology for biofuels and bioproducts · 2024Article
- Production of (R)-citramalate by engineeredMetabolic engineering communications · 2024Article
- Engineering a non-oxidative glycolysis pathway in escherichia coli for high-level citramalate production.Microbial cell factories · 2024Article
- Chemoautotrophic production of gaseous hydrocarbons, bioplastics and osmolytes by a novel Halomonas species.Biotechnology for biofuels and bioproducts · 2023Article
- Metabolic engineering of low-pH-tolerant non-model yeast,Metabolic engineering communications · 2023Article
- Analyzing Citramalic Acid Enantiomers in Apples and Commercial Fruit Juice by Liquid Chromatography-Tandem Mass Spectrometry with Pre-Column Derivatization.Molecules (Basel, Switzerland) · 2023Article
- Metabolic adjustments in response to ATP spilling by the small DX protein in aFrontiers in cell and developmental biology · 2023Article
- Segregationally stabilised plasmids improve production of commodity chemicals in glucose-limited continuous fermentation.Microbial cell factories · 2022Article
- Combination of Genome-Scale Models and Bioreactor Dynamics to Optimize the Production of Commodity Chemicals.Frontiers in molecular biosciences · 2022Article
- A Review of the Biotechnological Production of Methacrylic Acid.Frontiers in bioengineering and biotechnology · 2020Review
- Article
- Identification of novel citramalate biosynthesis pathways inFungal biology and biotechnology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
Citramalic acid is a central intermediate in a combined biocatalytic and chemocatalytic route to produce bio-based methylmethacrylate, the monomer used to manufacture Perspex and other high performance materials. We developed an engineered E. coli strain and a fed-batch bioprocess to produce citramalate at concentrations in excess of 80 g l
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.